-
URL1. Boyer D, Hu A, e al. (2024) LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) AMD Using the Lumithera Valeda Light Delivery System. Retina. Mar 1; 44(3), pp 487-497 [Accessed Apr 2024]
-
URL2. College of Optometrists. Blue blocking spectacle lenses. Clinical Guidance. Position statement. [Accessed Apr 2024]
-
URL3. College of Optometrists. Childhood-onset myopia management: Guidance for optometrists. Myopia. [Accessed Apr 2024]
-
URL4. Cote S, Zhang A, et al. (2020) Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cochrane Database Syst Rev. 18; 3, p 3 [Accessed Apr 2024]
-
URL5. Lawrenson J, Hull C, Downie L (2017) The effect of blue-light blocking spectacle lenses on visual performance, macular health and the sleep-wake cycle: a systematic review of the literature. Ophthalmic Physiol Opt; 37, pp 644–654 [Accessed Apr 2024]
-
URL6. Liu S, Tang S, Dong H, Huang X (2020) Intense pulsed light for the treatment of Meibomian gland dysfunction: A systematic review and meta analysis. Experimental and Therapeutic Medicine, 20, pp 1815-1821 [Accessed Apr 2024]
-
URL7. Pacific University Libraries (2024) What is Evidence-Based Medicine? Optometry Resources. [Accessed Apr 2024]
-
URL8. Singh S, Keller P, et al. (2023) Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database Syst Rev; 8, p 8 [Accessed Apr 2024]
-
URL9. Tashbayev B, Yazdani M, et al. (2020) Intense pulsed light treatment in meibomian gland dysfunction: A concise review, The Ocular Surface, Volume 18, Issue 4, pp 583-594 [Accessed Apr 2024]
-
URL1. College of Optometrists. Clinical Guidance. Using Evidence in Practice (for members only). [Accessed Apr 2024]
-
URL2. College of Optometrists. Clinical Management Guidelines. [Accessed Apr 2024]
-
URL3. Evidence-Based Practice (EBP) for Optometry website. [Accessed Apr 2024]